Pfizer's spokesperson said that the company will continue to engage with the DGCI and resubmit its approval request with additional information as it becomes available in the near future.
from Jagran Josh https://ift.tt/3rsG8GK
Pfizer's spokesperson said that the company will continue to engage with the DGCI and resubmit its approval request with additional information as it becomes available in the near future.
Subscribe To Get All The Latest Updates!

No comments:
Post a Comment